Sanjai Nagendra, MD | |
701 N First Street, Springfield, IL 62781 | |
(217) 788-3060 | |
(217) 788-5577 |
Full Name | Sanjai Nagendra |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 701 N First Street, Springfield, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649285453 | NPI | - | NPPES |
0361088361 | Medicaid | IL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | (Illinois) | Primary |
Entity Name | Pathology Associates Of Central Illinois Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548363138 PECOS PAC ID: 6103813449 Enrollment ID: O20040428000745 |
News Archive
Amgen today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care compared to BSC alone. The analysis used massively parallel, next-generation sequencing technology to investigate whether mutations in nine genes known to be mutated in colorectal cancer, including the previously unanalyzed exon 3 mutation of the KRAS gene, are predictive of response to Vectibix in metastatic colorectal cancer.
An oral abstract presented at the International Neuromodulation Society 12th World Congress today unveiled a new collaboration between U.S. and Chinese into non-invasive accupoint electrical stimulation in Crohn's disease.
WHO and the International Olympic Committee are teaming up to promote healthy lifestyle choices, including physical activity, sports for all, Tobacco Free Olympic Games, and the prevention of childhood obesity. As outlined in a memorandum of understanding signed today in Lausanne, the WHO and IOC will work at both the international and country level to promote activities and policy choices to help people reduce their risk of noncommunicable diseases such as cardiovascular disease, cancers, and diabetes.
The diabetes drug rosiglitazone (Avandia) can control inflammation leading to nerve damage and abnormal pain responses, suggests a paper in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
VaxGen, Inc., a biopharmaceutical company, and diaDexus, Inc., a privately held diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, announced today that they have entered into a definitive agreement under which VaxGen will acquire diaDexus in a stock-for-stock merger.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Sanjai Nagendra, MD 6450 Reliable Parkway, Chicago, IL 60686 Ph: () - | Sanjai Nagendra, MD 701 N First Street, Springfield, IL 62781 Ph: (217) 788-3060 |
News Archive
Amgen today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care compared to BSC alone. The analysis used massively parallel, next-generation sequencing technology to investigate whether mutations in nine genes known to be mutated in colorectal cancer, including the previously unanalyzed exon 3 mutation of the KRAS gene, are predictive of response to Vectibix in metastatic colorectal cancer.
An oral abstract presented at the International Neuromodulation Society 12th World Congress today unveiled a new collaboration between U.S. and Chinese into non-invasive accupoint electrical stimulation in Crohn's disease.
WHO and the International Olympic Committee are teaming up to promote healthy lifestyle choices, including physical activity, sports for all, Tobacco Free Olympic Games, and the prevention of childhood obesity. As outlined in a memorandum of understanding signed today in Lausanne, the WHO and IOC will work at both the international and country level to promote activities and policy choices to help people reduce their risk of noncommunicable diseases such as cardiovascular disease, cancers, and diabetes.
The diabetes drug rosiglitazone (Avandia) can control inflammation leading to nerve damage and abnormal pain responses, suggests a paper in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
VaxGen, Inc., a biopharmaceutical company, and diaDexus, Inc., a privately held diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, announced today that they have entered into a definitive agreement under which VaxGen will acquire diaDexus in a stock-for-stock merger.
› Verified 6 days ago
Cassi Brielle Grotepas, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 E Carpenter St, Springfield, IL 62769 Phone: 217-522-3117 | |
Dr. Onsi W Kamel, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 E Carpenter St, Springfield, IL 62769 Phone: 217-544-6464 | |
Cody Eric Freitag, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 E Carpenter St, Springfield, IL 62769 Phone: 217-522-3117 | |
Joan Barenfanger, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 701 N 1st St, Memorial Medical Center Laboratory Medicine, Springfield, IL 62781 Phone: 217-788-3672 Fax: 217-788-5577 | |
Michael Jon Beckmann, DO Pathology Medicare: Not Enrolled in Medicare Practice Location: 701 N 1st St, Memorial Medical Center, Springfield, IL 62781 Phone: 217-788-3064 Fax: 217-788-5577 | |
Patrick R Hemmer, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 E Carpenter St, Springfield, IL 62769 Phone: 217-544-6464 | |
Dr. Thomas Czeczok, Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 E Carpenter St, Springfield, IL 62769 Phone: 217-522-3117 |